论文信息 - Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer. - 字舞流文

Phase II trial of the oral PARP inhibitor olaparib in BRCA-deficient advanced breast cancer.

A. Tutt | J. Garber | M. Robson | J. Carmichael | M. Friedlander | S. Domchek | J. Weitzel | M. Audeh